Back to Search

Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia.

Paper Details
Authors:
Ellen Donges
Christine E. Staatz
Helen Benham
Paul Kubler
Samantha Hollingworth
Publication Date: 2018-03-01
Pharmaceutical Economics and PolicyEconomics, Econometrics and FinanceEconomics and EconometricsSocial Sciences
Access Restricted

This paper is not available under open access. The publisher restricts full-text distribution.

You may still be able to access it through your institution, request it directly from the author, or view the abstract and citation details.

External Resources

Paper information is provided by public research databases. Summaries are generated to aid understanding and may not reflect the complete scope of the work. For the authoritative version, please refer to the original publication.